AURORA LABS LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.038 AUD | -2.56% |
|
+35.71% | +31.03% |
| Apr. 22 | Aurora Labs to Raise AU$2 Million via Placement | MT |
| Apr. 15 | Aurora Labs Obtains Japanese Patent for Multi-Concurrent Printing Technology | MT |
Valuation
| Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 32.35 | 28.36 | 6.92 | 11.31 | 6.998 | 5.162 |
| Enterprise Value (EV) 1 | 28.56 | 26.11 | 6.589 | 10.19 | 5.212 | 4.241 |
| P/E ratio | -5.42 x | -3.19 x | -0.75 x | -2.43 x | -2.08 x | -1.45 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 98 x | 31.5 x | 16.7 x | 65.9 x | 217 x | 38.4 x |
| EV / Revenue | 86.6 x | 29 x | 15.9 x | 59.4 x | 162 x | 31.5 x |
| EV / EBITDA | -4.09 x | -2.77 x | -0.75 x | -2 x | -1.37 x | -1.23 x |
| EV / FCF | -5.34 x | -4.11 x | -1.29 x | -7.49 x | -2.65 x | -2.23 x |
| FCF Yield | -18.7% | -24.3% | -77.4% | -13.4% | -37.7% | -44.9% |
| Price to Book | 5.04 x | 4.94 x | 2.04 x | 5.14 x | 2.66 x | 3.54 x |
| Nbr of stocks (in thousands) | 65,354 | 88,635 | 117,280 | 152,896 | 184,158 | 245,808 |
| Reference price 2 | 0.4950 | 0.3200 | 0.0590 | 0.0740 | 0.0380 | 0.0210 |
| Announcement Date | 8/21/18 | 8/27/19 | 8/31/20 | 8/27/21 | 8/24/22 | 8/25/23 |
1AUD in Million2AUD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 0.33 | 0.9016 | 0.4149 | 0.1716 | 0.0322 | 0.1346 |
| EBITDA 1 | -6.985 | -9.413 | -8.759 | -5.105 | -3.804 | -3.452 |
| EBIT 1 | -7.144 | -9.589 | -9.028 | -5.215 | -3.883 | -3.521 |
| Operating Margin | -2,164.93% | -1,063.55% | -2,176.07% | -3,038.68% | -12,061.49% | -2,616.47% |
| Earnings before Tax (EBT) 1 | -7.064 | -9.506 | -9.399 | -5.22 | -3.886 | -3.551 |
| Net income 1 | -5.531 | -7.643 | -8.156 | -4.423 | -3.149 | -2.962 |
| Net margin | -1,676.29% | -847.7% | -1,965.93% | -2,577.06% | -9,779.57% | -2,201.08% |
| EPS 2 | -0.0913 | -0.1002 | -0.0785 | -0.0305 | -0.0183 | -0.0144 |
| Free Cash Flow 1 | -5.352 | -6.352 | -5.101 | -1.361 | -1.965 | -1.906 |
| FCF margin | -1,621.96% | -704.5% | -1,229.47% | -792.98% | -6,103.17% | -1,416.19% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 8/21/18 | 8/27/19 | 8/31/20 | 8/27/21 | 8/24/22 | 8/25/23 |
1AUD in Million2AUD
Estimates
Balance Sheet Analysis
| Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | 3.79 | 2.25 | 0.33 | 1.12 | 1.79 | 0.92 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | -5.35 | -6.35 | -5.1 | -1.36 | -1.96 | -1.91 |
| ROE (net income / shareholders' equity) | -83.7% | -125% | -179% | -158% | -130% | -145% |
| ROA (Net income/ Total Assets) | -59.5% | -78.5% | -86.4% | -82% | -77.5% | -79.6% |
| Assets 1 | 9.3 | 9.733 | 9.443 | 5.396 | 4.06 | 3.719 |
| Book Value Per Share 2 | 0.1000 | 0.0600 | 0.0300 | 0.0100 | 0.0100 | 0.0100 |
| Cash Flow per Share 2 | 0.0600 | 0.0400 | 0.0100 | 0.0100 | 0.0100 | 0 |
| Capex 1 | 0.28 | 0.16 | 0.37 | 0 | 0.05 | 0.02 |
| Capex / Sales | 85.96% | 18.18% | 88.77% | 1.58% | 150.39% | 17.37% |
| Announcement Date | 8/21/18 | 8/27/19 | 8/31/20 | 8/27/21 | 8/24/22 | 8/25/23 |
1AUD in Million2AUD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| +31.03% | 7.18M | |
| -29.83% | 699M | |
| -45.98% | 458M | |
| +9.40% | 271M | |
| -17.72% | 135M |
- Stock Market
- Equities
- A3D Stock
- Financials Aurora Labs Limited
